The Impact of oral medication on cognitive function and delirium in patients with acute congestive heart failure

The Impact of oral medication on cognitive function and delirium in patients with acute congestive heart failure - Oral medication and cognitive function in heart failure patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029773

Enrollment

200

Registered

2017-11-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute heart failure

Interventions

conventional intravenous treatment oral treatment (avoiding continuous intravenous therapy)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: agreement by patients beyond 65 years old diagnosed with acute congestive heart failure

Exclusion criteria

Exclusion criteria: acute myocardial infarction severe respiratory failure (PaO2<60Torr, and/or SPO2<90% on oxygen administration) shock vital (sBP<90mmHg)

Design outcomes

Primary

Measure	Time frame
frequency of delirium	—

Secondary

Measure	Time frame
cognitive function	—

Countries

Japan

Contacts

Public ContactKazutaka Ueda

Tokyo Metropolitan Police Hospital Department of Cardiology

ueda-cib@umin.ac.jp+81-3-5343-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026